Inflammatory bowel disease and anxiety: Links, risks, and challenges faced

Clinical and Experimental Gastroenterology

Volumn 8, Issue , 2015, Pages 111-117

  Bannaga, Ayman S ^a   Selinger, Christian P ^b  

^a DONCASTER ROYAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Anxiety; Crohn s disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ABDOMINAL PAIN; AGE; ANXIETY DISORDER; BLOODY DIARRHEA; CLINICAL EFFECTIVENESS; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DEFECATION; DEFECATION URGENCY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FATIGUE; FECES INCONTINENCE; GROUP THERAPY; HEALTH EDUCATION; HUMAN; HYPNOSIS; INFLAMMATORY BOWEL DISEASE; NONHUMAN; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; REVIEW; RISK FACTOR; SEX DIFFERENCE; STRESS;

EID: 84936947269     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S57982     Document Type: Review

References (63)

1. Podolsky D. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
2. Kucharzik T, Maaser C, Lugering A, et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis. 2006;12:1068-1083.
3. Sartor R. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3: 390-407.
4. The Publications Team. Information about IBD. Available from: http://www.crohnsandcolitis.org.uk/information-and-support/information-about-ibd/what-is-IBD. Accessed December 6, 2014.
5. Magalhães J, Castro F, Carvalho P, et al. Quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors. Arq Gastroenterol. 2014;51:192-197.
6. Devlen J, Beusterien K, Yen L, et al. The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis. 2014;20:545-552.
7. Papathanasopoulos A, Van Oudenhove L, Katsanos K, et al. Severity of fecal urgency and incontinence in inflammatory bowel disease: clinical, manometric and sonographic predictors. Inflamm Bowel Dis. 2013;19:2450-2456.
8. Dibley L, Norton C. Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19:1450-1462.
9. Selinger C, Andrews J, Titman A, et al. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:644-650.
10. Jewell D. Ulcerative Colitis. In: Warrell D, Cox T, Firth J, editors. Oxford Textbook of Medicine. 5th ed. Oxford, UK: Oxford University Press; 2010:2371-2383.
11. Parkes M. Crohn's Disease. In: Warrell D, Cox T, Firth J editors. Oxford Textbook of Medicine. 5th ed. Oxford, UK: Oxford University Press; 2010:2361-2370.
12. Lutgens M, Vermeire S, Van Oijen M, et al. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015;13:148-154.
13. Scarpa M, Castagliuolo I, Castoro C, et al. Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol. 2014;20:6774-6785.
14. Tyson G, El-Serag H. Risk factors of cholangiocarcinoma. Hepatology. 2011;54:173-184.
15. Selinger C, Leong R. Mortality from inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18:1566-1572.
16. Monstada I, Øistein H, Solberga I, et al. Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies. Ann Gastroenterol. 2014;27:95-104.
17. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Available from: http://www.who.int/classifications/icd/en/bluebook.pdf. Accessed December 6, 2014.
18. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002;53:859-863.
19. Patten S, Beck C, Kassam A, et al. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry. 2005;50:195-202.
20. Scott K, Bruffaerts R, Tsang A, et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health surveys. J Affect Disord. 2007;103:113-120.
21. Andrews H, Barczak P, Allan R. Psychiatric illness in patients with inflammatory bowel disease. Gut. 1987;28:1600-1604.
22. Helzer J, Chammas S, Norland C, et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology. 1984;86:324-330.
23. Schwartz R, Schwartz I. Psychiatric disorders associated with Crohn's disease. Int J Psychiatry Med.1982;12:67-73.
24. Tartar R, Switala J, Carra J, et al. Inflammatory bowel disease: psychiatric status of patients before and after disease onset. Int J Psychiatry Med. 1987;17:173-181.
25. Walker E, Roy-Byrne P, Katon W, et al. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry.1990;147:1656-1661.
26. Addolorato G, Capristo E, Stefanini G, et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol. 1997;32:1013-1021.
27. Magni G, Bernasconi G, Mauro P, et al. Psychiatric diagnoses in ulcerative colitis. A controlled study. Br J Psychiatry.1991;158:413-415.
28. Robertson D, Ray J, Diamond I, et al. Personality profile and affective state of patients with inflammatory bowel disease. Gut. 1989;30: 623-626.
29. Goodhand J, Wahed M, Mawdsley J, et al. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012;18:2301-2309.
30. Nahon S, Lahmek P, Durance C, et al. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18: 2086-2091.
31. Bennebroek Evertsz F, Thijssens N, Stokkers P. et al. Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need? J Crohns Colitis. 2012;6:68-76.
32. Walker J, Ediger J, Graff L, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103:1989-1997.
33. Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000;95:1213-1220.
34. Bitton A, Dobkin P, Edwardes M, et al. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut. 2008;57:1386-1392.
35. Mawdsley J, Rampton D. Psychological stress in inflammatory bowel disease. Gut. 2005;54:1481-1491.
36. Chen J, Winston J, Fu Y, et al. Genesis of anxiety, depression and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation. Am J Physiol Regul Integr Comp Physiol. 2015;1:18-27.
37. Filipovic B, Filipovic B. Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol. 2014;20:3552-3563.
38. Bryant R, van Langenberg D, Holtmann G, et al. Functional gastrointestinal disorders in IBD. J Gastroenterol Hepatol. 2011;26:916-923.
39. Kovacs Z, Kovacs F. Depressive and anxiety symptoms, dysfunctional attitudes, and social aspects in irritable bowel syndrome and inflammatory bowel disease. Int J Psych Med. 2007;37:245-255.
40. Kim E, Cho K, Park K, et al. Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J Clin Gastroenterol. 2013;47:38-44.
41. Trachter A, Rogers A, Leiblum S. Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm Bowel Dis. 2002;8:413-421.
42. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006;12:697-707.
43. Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1994;89:1219-1225.
44. Bernstein C, Singh S, Graff L, et al. A prospective population based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105:1994-2002.
45. Knowles S, Wilson J, Wilkinson A, et al. Psychological well-being and quality of life in Crohn's disease patients with an ostomy: a preliminary investigation. J Wound Ostomy Continence Nurs. 2013;40:623-629.
46. Ananthakrishnan A, Gainer V, Cai T, et al. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2013;108:594-601.
47. Selinger C, Lal S, Eaden J, et al. Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease. J Crohns Colitis. 2013;7:214-218.
48. Larsson K, Sundberg Hjelm M, Karlbom U, et al. A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis. Scand J Gastroenterol. 2003;38:763-769.
49. Bonaz B and Bemestein C. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144:36-49.
50. Means-Christensen A, Sherbourne C, Roy-Byrne P, et al. Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector. Gen Hosp Psychiatry. 2006;28:108-118.
51. Kunzendorf S, Jantschek G, Straubinger K, et al. The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:33-41.
52. Collins K, Westra H, Dozois D, et al. Gaps in accessing treatment for anxiety and depression: challenges for the delivery of care. Clin Psychol Rev. 2004;24:583-616.
53. Wang P, Lane M, Olfson M, et al. Twelve-month use of mental health services in the United States: results from the national co-morbidity survey replication. Arch Gen Psychiatry. 2005;62:629-640.
54. Prins M, Verhaak P, Bensing J, et al. Health beliefs and perceived need for mental health care of anxiety and depression-the patients' perspective explored. Clin Psychol Rev. 2008;28:1038-1058.
55. Iglesias-Rey M, Barreiro-de Acosta M, Caamaño-Isorna F, et al. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:92-102.
56. Hansen R, Gartlehner G, Lohr K, et al. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann of Intern Med. 2005;143:415-426.
57. Bandelow B, Seidler-Brandler U, Becker A, et al. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry. 2007;8:175-187.
58. Norton P, Price E. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis. 2007;195:521-531.
59. Cuijpers P, van Straten A, van Oppen P, et al. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J Clin Psychiatry. 2008;69:1675-1685.
60. Reigada L, Benkov K, Bruzzese J, et al. Integrating illness concerns into cognitive behavioral therapy for children and adolescents with inflammatory bowel disease and co-occurring anxiety. J Spec Pediatr Nurs. 2013;18:133-143.
61. Timmer A, Preiss J, Motschall E, et al. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2011;2:CD006913.
62. Moser G. The role of hypnotherapy for the treatment of inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol. 2014;8: 601-606.
63. Keefer L, Taft T, Kiebles J, et al. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013;38:761-771.